The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized control trial of triapine plus lutetium 177 DOTATATE versus lutetium 177 DOTATATE alone for well-differentiated somatostatin receptor-positive neuroendocrine tumors.
 
Aman Chauhan
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Crinetics Pharmaceuticals; Ipsen; Lexicon; Seneca Therapeutics; TerSera
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck KGaA (Inst); Nano Therapeutics (Inst); TerSera (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
 
Charles Kunos
No Relationships to Disclose
 
Susanne M. Arnold
Consulting or Advisory Role - Penn State Cancer Institute
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics, Inc (Inst); Ellipses Pharma (Inst); Exelixis (Inst); Fortrea Inc (Inst); Gilead Sciences (Inst); Incyte (Inst); Kinnate Biopharma (Inst); Kura Oncology (Inst); Lilly (Inst); Lisata Therapeutics, Inc. (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Ohio State University (Inst); Syneos Health (Inst)
 
Heidi Weiss
No Relationships to Disclose
 
S. Percy Ivy
No Relationships to Disclose
 
Steven Gore
No Relationships to Disclose
 
Lawrence Rubinstein
No Relationships to Disclose
 
Lorraine Pelosof
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - Voisin Consulting (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Research Funding - TriSalus Life Sciences (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
Expert Testimony - Astellas Pharma; AstraZeneca/Merck
(OPTIONAL) Uncompensated Relationships - Applied Isotope Technologies; Qrono
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics; VesiCure Technologies
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife; Loxo/Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages
Travel, Accommodations, Expenses - Caris Life Sciences
 
William Edgar Carson
No Relationships to Disclose
 
Elise C. Kohn
No Relationships to Disclose
 
Lowell Brian Anthony
No Relationships to Disclose